Explore Products

Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies

  • AcceGen R&D Team
  • Jul 29, 2021
  • 15

You Might Also Like

AcceGen Scroll Top Button